BR112023002395A2 - Sistema de baculovírus modificado para produção aprimorada de dna com extremidades fechadas (cedna) - Google Patents
Sistema de baculovírus modificado para produção aprimorada de dna com extremidades fechadas (cedna)Info
- Publication number
- BR112023002395A2 BR112023002395A2 BR112023002395A BR112023002395A BR112023002395A2 BR 112023002395 A2 BR112023002395 A2 BR 112023002395A2 BR 112023002395 A BR112023002395 A BR 112023002395A BR 112023002395 A BR112023002395 A BR 112023002395A BR 112023002395 A2 BR112023002395 A2 BR 112023002395A2
- Authority
- BR
- Brazil
- Prior art keywords
- cedna
- ended dna
- baculovirus system
- dna production
- closed
- Prior art date
Links
- 241000701447 unidentified baculovirus Species 0.000 title abstract 3
- 241000238631 Hexapoda Species 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14051—Methods of production or purification of viral material
- C12N2710/14052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/55—Vectors comprising a special origin of replication system from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SISTEMA DE BACULOVÍRUS MODIFICADO PARA PRODUÇÃO APRIMORADA DE DNA COM EXTREMIDADES FECHADAS (ceDNA). A presente invenção refere-se a um vetor de expressão de baculovírus recombinante (rBEV) para a produção de DNA com extremidades fechadas (ceDNA) em células de inseto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063069115P | 2020-08-23 | 2020-08-23 | |
PCT/US2021/047202 WO2022046665A1 (en) | 2020-08-23 | 2021-08-23 | MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA) |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112023002395A2 true BR112023002395A2 (pt) | 2023-03-21 |
Family
ID=77775013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023002395A BR112023002395A2 (pt) | 2020-08-23 | 2021-08-23 | Sistema de baculovírus modificado para produção aprimorada de dna com extremidades fechadas (cedna) |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220090130A1 (pt) |
EP (1) | EP4199971A1 (pt) |
JP (1) | JP2023538666A (pt) |
KR (1) | KR20230046323A (pt) |
CN (1) | CN116194152A (pt) |
AU (1) | AU2021330936A1 (pt) |
BR (1) | BR112023002395A2 (pt) |
CA (1) | CA3189673A1 (pt) |
IL (1) | IL300445A (pt) |
MX (1) | MX2023002221A (pt) |
TW (1) | TW202227466A (pt) |
WO (1) | WO2022046665A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT3889173T (pt) | 2013-02-15 | 2023-10-10 | Bioverativ Therapeutics Inc | Gene do fator viii otimizado |
RS63548B1 (sr) | 2016-02-01 | 2022-09-30 | Bioverativ Therapeutics Inc | Optimizovani geni faktora viii |
KR20240049332A (ko) * | 2021-08-23 | 2024-04-16 | 바이오버라티브 테라퓨틱스 인크. | 최적화된 인자 viii 유전자 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1395293B1 (en) | 2001-05-14 | 2009-07-22 | Gbp Ip, Llc | Lentiviral vectors encoding clotting factors for gene therapy |
US8501464B2 (en) | 2003-04-24 | 2013-08-06 | Ospedale San Raffaele S.R.L. | Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
KR20130114758A (ko) | 2005-05-27 | 2013-10-17 | 오스페달레 산 라파엘 에스.알.엘. | Mi-rna를 포함하는 유전자 벡터 |
WO2010055413A1 (en) | 2008-11-12 | 2010-05-20 | Fondazione Centro San Raffaele Del Monte Tabor | Gene vector for inducing transgene-specific immune tolerance |
KR101793615B1 (ko) | 2009-04-30 | 2017-11-03 | 오스페달레 산 라파엘 에스.알.엘. | 유전자 벡터 |
EP2292781A1 (en) * | 2009-08-17 | 2011-03-09 | Genethon | Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
JP2016537028A (ja) | 2013-11-18 | 2016-12-01 | クリスパー セラピューティクス アーゲー | Crispr−casシステムの材料及び方法 |
TWI707951B (zh) | 2015-04-08 | 2020-10-21 | 美商健臻公司 | 過大腺相關載體之製造 |
MX2018003337A (es) * | 2015-09-17 | 2018-08-16 | Alternative Gene Expression Sl | Expresion de proteinas recombinantes en pupas de trichoplusia ni. |
DK3423110T3 (da) | 2016-03-03 | 2021-11-15 | Univ Massachusetts | Lineært duplex-dna med lukket ende til ikke-viral genoverførsel |
FR3054841B1 (fr) * | 2016-08-05 | 2021-01-29 | Centre Nat Rech Scient | Systeme d'expression baculovirus |
SG11202000764RA (en) | 2017-08-09 | 2020-02-27 | Bioverativ Therapeutics Inc | Nucleic acid molecules and uses thereof |
MA50100A (fr) | 2017-09-08 | 2020-07-15 | Generation Bio Co | Adn à extrémité fermée (cedna) modifié |
WO2019165050A1 (en) * | 2018-02-22 | 2019-08-29 | Generation Bio Co. | Controlled expression of transgenes using close-ended dna (cedna) vectors |
CN113227385A (zh) | 2018-08-09 | 2021-08-06 | 比奥维拉迪维治疗股份有限公司 | 核酸分子及其用于非病毒基因疗法的用途 |
US20220042040A1 (en) * | 2018-09-17 | 2022-02-10 | Universität Für Bodenkultur Wien | Dual vector system for improved production of proteins in animal cells |
-
2021
- 2021-08-23 BR BR112023002395A patent/BR112023002395A2/pt unknown
- 2021-08-23 KR KR1020237009807A patent/KR20230046323A/ko unknown
- 2021-08-23 JP JP2023513100A patent/JP2023538666A/ja active Pending
- 2021-08-23 CA CA3189673A patent/CA3189673A1/en active Pending
- 2021-08-23 MX MX2023002221A patent/MX2023002221A/es unknown
- 2021-08-23 CN CN202180051945.4A patent/CN116194152A/zh active Pending
- 2021-08-23 EP EP21770380.0A patent/EP4199971A1/en active Pending
- 2021-08-23 US US17/409,774 patent/US20220090130A1/en active Pending
- 2021-08-23 WO PCT/US2021/047202 patent/WO2022046665A1/en unknown
- 2021-08-23 AU AU2021330936A patent/AU2021330936A1/en active Pending
- 2021-08-23 TW TW110131139A patent/TW202227466A/zh unknown
- 2021-08-23 IL IL300445A patent/IL300445A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2023002221A (es) | 2023-03-15 |
KR20230046323A (ko) | 2023-04-05 |
US20220090130A1 (en) | 2022-03-24 |
WO2022046665A1 (en) | 2022-03-03 |
CA3189673A1 (en) | 2022-03-03 |
EP4199971A1 (en) | 2023-06-28 |
AU2021330936A1 (en) | 2023-05-04 |
TW202227466A (zh) | 2022-07-16 |
IL300445A (en) | 2023-04-01 |
CN116194152A (zh) | 2023-05-30 |
JP2023538666A (ja) | 2023-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112023002395A2 (pt) | Sistema de baculovírus modificado para produção aprimorada de dna com extremidades fechadas (cedna) | |
BR112016002614A8 (pt) | Imunocitoquina, ácido nucleico, vetor, célula hospedeira e composição farmacêutica | |
BR112013005872A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
BR112016002494A2 (pt) | Proteí-nas construídas com um sítio de clivagem de protease, ácido nucléico, vetor, célula e processo de engenharia de uma proteína recombinante e de um grande número de variantes de ácidos nucleicos que codificam proteínas recombinantes | |
AR091418A1 (es) | Sistema de expresion en una linea celular de ovario de hamster chino (cho) | |
EA201190178A1 (ru) | Замещённые нуклеозидные и нуклеотидные аналоги | |
BR112012009668A2 (pt) | proteínas engendradas com dedo de zinco que visam genes vegetais envolvidos na biossíntese de ácidos graxos. | |
MX352205B (es) | Sistemas de expresion. | |
BR112015010550A2 (pt) | Usos de lys-c, métodos para fabricação de um polipeptídeo proteoliticamente processado, para fabricação de um polipeptídeo proteoliticamente ativo, para avaliação para um inibidor do polipeptídeo proteoliticamente ativo, e para geração de fragmentos de polipeptídeo, composições, polipeptídeo proteoliticamente ativo, uso do mesmo, molécula de ácido nucléico, vetor, célula e uso de um polipeptídeo processado | |
AR083354A1 (es) | Polipeptidos variantes cbh i (celobiohidrolasas i) con reducida inhibicion de producto | |
BR112015005384A2 (pt) | neurotoxinas clostridium botuliem recombinantes | |
BR112017020308A2 (pt) | udp-glicosiltransferases | |
BR112017025923A2 (pt) | molécula de ácido nucleico recombinante, molécula de aminoácido recombinante, construto de expressão recombinante, vetor recombinante, micro-organismo recombinante, composição, métodos para produção de um micro-organismo recombinante e para cultivo e crescimento de um micro-organismo geneticamente modificado, uso de uma molécula de ácido nucleico recombinante, e, processo para produção fermentativa de um composto. | |
BR112019005886A2 (pt) | tratamento com água de material lipídico | |
BR112016016014A2 (pt) | gene resistente a inseto derivado de ser humano e anticorpo de cadeia única de idiotipo de toxina anti-cry1b codificado pelo mesmo e aplicação do mesmo | |
BR112018001121A2 (pt) | vetor recombinante do vírus orf (orfv), célula, composição, uso de um vetor recombinante de orfv, e, molécula de ácido nucleico | |
BR112014027239A2 (pt) | peptídeo, método de identificação de peptídeos, método para o tratamento de câncer, nucleotídeo, vetor, uso de um peptídeo e invenção | |
BR112021024080A2 (pt) | Construtos de rnai para inibir a expressão de scap e métodos de uso dos mesmos | |
PE20211225A1 (es) | Constructos de arni para inhibir la expresion de pnpla3 | |
MX2015016371A (es) | Métodos y composiciones para ensamblaje templado de heterocompuestos específicos de acido nucleico. | |
MX2020004211A (es) | Mitoflavoscinas: la fijacion como objetivo de enzimas que contienen flavina elimina celulas madre cancerosas (cscs) al inhibir la respiracion mitocondrial. | |
BR112022000297A2 (pt) | Conjugados de peptídeos de agentes de alvo de microtúbulos como terapêuticos | |
BR112017002750A2 (pt) | compostos de sulfonilaminobenzamida | |
BR112022010839A2 (pt) | Compostos heterocíclicos funcionalizados como moduladores de estimulador de genes de interferon (sting) | |
BR112017008702A2 (pt) | ?mutante de endoxilanase, dna, vetor, célula, método de produção de mutantes de endoxilanase, composição enzimática e método de produção de solução de açúcar? |